Anti-VEGF/Immunotherapy Combinations in Kidney Cancer – OncLive
|
Anti-VEGF/Immunotherapy Combinations in Kidney Cancer
OncLive Martin H. Voss, MD: We have several combinations testing with immunotherapy plus targeted therapeutics, such as a VEGF receptor TKI, under investigation presently. And that goes back to the fact that many of the medications we already have on the … |
